Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01474811 · ClinicalTrials.gov registry record

HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network

A clinical trial of Hepatitis C, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
13,559
Enrollment target
20
Study locations

NCT01474811 is a study of Hepatitis C that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 13,559 participants, above the 1,762-participant average among 106 other Hepatitis C trials with a reported enrollment target (670% higher). The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01474811, a study of Hepatitis C, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
13,559 participants
Enrollment target
20
Study locations

Study Summary

The primary purpose of the HCV-TARGET study is to establish a nationwide registry of patients undergoing treatment with antiviral therapies for chronic hepatitis C (HCV) at both academic and community practices.

Conditions Studied

Hepatitis C

Study Locations (20)

California

  • Scripps - La Jolla
  • UCSD Medical Center - San Diego
  • UCSF/San Fran General Hospital - San Francisco
  • Univ of California, San Francisco - San Francisco

Florida

  • University of Florida - Gainesville
  • University of Miami Miller School of Medicine - Miami
  • Orlando Immunology Center - Orlando

Illinois

  • Lake Shore Gastroenterology & Liver Disease Inst. - Chicago
  • Northwestern University - Chicago
  • University of Chicago - Chicago

District of Columbia

  • Georgetown University - Washington D.C.
  • Howard University - Washington D.C.

Georgia

  • Atlanta Medical Center - Atlanta
  • Emory University - Atlanta

Arizona

  • Mayo Clinic AZ - Phoenix

Arkansas

  • Liver Wellness Center - Little Rock

Colorado

  • University of Colorado, Denver - Denver

Trial Details

FieldValue
Enrollment Target 13,559 participants
Start Date 2011-11
Est. Completion 2022-09-09

Sponsor

University of North Carolina, Chapel Hill

1,109 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01474811

The ClinicalTrials.gov registry entry for NCT01474811 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13,559 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,762-participant average among 106 other Hepatitis C trials with a reported enrollment target (670% higher). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hepatitis C appearing as the primary indexed condition, and to 0 interventions.

NCT01474811 reports 20 study locations spanning 11 distinct geographic areas - top geographies include California, Florida, Illinois.

Frequently Asked Questions

What is clinical trial NCT01474811 about?

NCT01474811 is a clinical study titled "HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network". The primary purpose of the HCV-TARGET study is to establish a nationwide registry of patients undergoing treatment with antiviral therapies for chronic hepatitis C (HCV) at both academic and community practices.

What is the current status of trial NCT01474811?

This trial is currently completed. The enrollment target is 13,559 participants. The study started on 2011-11. Estimated completion is 2022-09-09.

What conditions does trial NCT01474811 study?

This clinical trial studies the following conditions: Hepatitis C.

Who is sponsoring clinical trial NCT01474811?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01474811 being conducted?

This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hepatitis C

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hepatitis C

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.